TCI Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.19M Buy
6,824
+10
+0.1% +$10.2K 0.35% 33
2026
Q1
$6.27M Sell
6,814
-1,237
-15% -$1.25M 0.33% 37
2025
Q4
$8.65M Sell
8,051
-36
-0.4% -$34.4K 0.48% 31
2025
Q3
$6.17M Buy
8,087
+40
+0.5% +$29.8K 0.37% 35
2025
Q2
$6.27M Sell
8,047
-46
-0.6% -$35.7K 0.43% 31
2025
Q1
$6.68M Sell
8,093
-134
-2% -$112K 0.54% 27
2024
Q4
$6.35M Buy
8,227
+31
+0.4% +$25.7K 0.53% 26
2024
Q3
$7.26M Buy
8,196
+39
+0.5% +$35.1K 0.61% 24
2024
Q2
$7.39M Buy
8,157
+12
+0.1% +$9.6K 0.7% 24
2024
Q1
$6.34M Buy
8,145
+44
+0.5% +$31.3K 0.62% 26
2023
Q4
$4.72M Buy
8,101
+637
+9% +$372K 0.5% 29
2023
Q3
$4.01M Buy
7,464
+10
+0.1% +$5.15K 0.51% 29
2023
Q2
$3.5M Buy
7,454
+49
+0.7% +$20.5K 0.45% 30
2023
Q1
$2.54M Buy
7,405
+182
+3% +$61.4K 0.33% 35
2022
Q4
$2.64M Sell
7,223
-67
-0.9% -$23.8K 0.37% 34
2022
Q3
$2.36M Sell
7,290
-65
-0.9% -$20.6K 0.38% 30
2022
Q2
$2.38M Buy
7,355
+597
+9% +$179K 0.36% 32
2022
Q1
$1.94M Sell
6,758
-381
-5% -$98.1K 0.29% 42
2021
Q4
$1.97M Sell
7,139
-441
-6% -$112K 0.29% 38
2021
Q3
$1.75M Sell
7,580
-469
-6% -$116K 0.27% 40
2021
Q2
$1.85M Sell
8,049
-13
-0.2% -$2.61K 0.31% 35
2021
Q1
$1.51M Sell
8,062
-5
-0.1% -$978 0.64% 36
2020
Q4
$1.36M Sell
8,067
-6,428
-44% -$960K 0.61% 37
2020
Q3
$2.15M Sell
14,495
-300
-2% -$46.4K 0.85% 26
2020
Q2
$2.43M Buy
14,795
+12
+0.1% +$1.84K 1.04% 22
2020
Q1
$2.05M Buy
14,783
+2,065
+16% +$284K 1.01% 21
2019
Q4
$1.67M Buy
12,718
+590
+5% +$68.4K 0.65% 37
2019
Q3
$1.36M Sell
12,128
-84
-0.7% -$9.35K 0.6% 41
2019
Q2
$1.35M Sell
12,212
-662
-5% -$78K 0.61% 42
2019
Q1
$1.67M Sell
12,874
-17
-0.1% -$2.07K 0.73% 36
2018
Q4
$1.49M Sell
12,891
-638
-5% -$71.3K 0.72% 37
2018
Q3
$1.45M Sell
13,529
-687
-5% -$68.7K 0.61% 42
2018
Q2
$1.21M Sell
14,216
-2,265
-14% -$186K 0.54% 48
2018
Q1
$1.27M Sell
16,481
-452
-3% -$36.4K 0.59% 43
2017
Q4
$1.43M Buy
16,933
+75
+0.4% +$6.38K 0.63% 38
2017
Q3
$1.44M Sell
16,858
-494
-3% -$40.5K 0.71% 37
2017
Q2
$1.43M Sell
17,352
-240
-1% -$19.6K 0.73% 35
2017
Q1
$1.48M Buy
17,592
+3,086
+21% +$247K 0.77% 33
2016
Q4
$1.07M Sell
14,506
-172
-1% -$12.8K 0.56% 45
2016
Q3
$1.18M Buy
14,678
+68
+0.5% +$5.44K 0.64% 40
2016
Q2
$1.15M Sell
14,610
-159
-1% -$12K 0.64% 40
2016
Q1
$1.06M Buy
14,769
+420
+3% +$31.8K 0.59% 43
2015
Q4
$1.21M Buy
14,349
+76
+0.5% +$6.31K 0.67% 35
2015
Q3
$1.2M Buy
14,273
+2,597
+22% +$219K 0.72% 35
2015
Q2
$975K Buy
11,676
+106
+0.9% +$8.08K 0.56% 46
2015
Q1
$841K Sell
11,570
-449
-4% -$32K 0.53% 48
2014
Q4
$829K Sell
12,019
-95
-0.8% -$6.41K 0.51% 47
2014
Q3
$786K Sell
12,114
-488
-4% -$30.9K 0.5% 48
2014
Q2
$783K Hold
12,602
0.47% 48
2014
Q1
$741K Hold
12,602
0.48% 48
2013
Q4
$643K Sell
12,602
-25
-0.2% -$1.25K 0.4% 54
2013
Q3
$636K Buy
12,627
+25
+0.2% +$1.31K 0.48% 49
2013
Q2
$619K Buy
+12,602
New +$686K 0.47% 53

Other funds holding LLY

TCI Wealth Advisors's LLY Position: Q2 2026 in Review

TCI Wealth Advisors increased its Eli Lilly (LLY) stake by 0.15% in Q2 2026, buying an estimated $10.2K and bringing the position to 6,824 shares worth $8.19M. The position accounts for 0.35% of the portfolio, ranked #33.

TCI Wealth Advisors first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.65M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TCI Wealth Advisors held 6,824 shares of Eli Lilly worth $8.19M as of Q2 2026.
  • TCI Wealth Advisors bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.35% of TCI Wealth Advisors's portfolio in Q2 2026, its #33 holding.
  • TCI Wealth Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • TCI Wealth Advisors's Eli Lilly position peaked at $8.65M in Q4 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TCI Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.